Alvinkctan personal page - To The Moon

Alvinkctan

Alvinkctan

No personal profile

169Follow

6Followers

1Topic

0Badge

2021-08-03

Great

Wall Street avoids delta anxiety to push stocks near record highs

2022-01-08

Great. Thanks

3 COVID Stocks That Will Make Billions in 2022

2021-12-29

😂😢

Elon Musk Sells $1.02 Billion Worth of Tesla Shares

2021-08-07

Like

Sorry, the original content has been removed

2021-06-29

Interesting

Crypto stocks strengthen with bitcoin

2021-06-29

Cool

2 Robinhood Stocks That Could Crush Dogecoin

2022-01-04

, 👍

Sorry, the original content has been removed

2022-01-05

👍

Dow posts closing record high for 2nd day, boosted by banks

2022-08-20

Noted with thanks.

These 4 Singapore Stocks are Trading at a 52-Week Low: Are They a Buy?

2022-04-26

👍

@Alvin Chow:Investing with numbers or stories

2022-02-19

Noted. Thank you.

昨夜今晨 | 俄乌局势惊扰市场！美股连跌两周

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3572299667195288","uuid":"3572299667195288","gmtCreate":1609208570399,"gmtModify":1624976942707,"name":"Alvinkctan","pinyin":"alvinkctan","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":169,"tweetSize":16,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9998177903,"gmtCreate":1660960425205,"gmtModify":1676536430704,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Noted with thanks.&nbsp;","listText":"Noted with thanks.&nbsp;","text":"Noted with thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9998177903","repostId":"1133089120","repostType":4,"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9087999050,"gmtCreate":1650936800470,"gmtModify":1676534819379,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9087999050","repostId":"9084693844","repostType":1,"repost":{"id":9084693844,"gmtCreate":1650852645978,"gmtModify":1676534803608,"author":{"id":"3558908080415665","authorId":"3558908080415665","name":"Alvin Chow","avatar":"https://static.tigerbbs.com/2abf7014742f3e282e9781e945db75b0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558908080415665","authorIdStr":"3558908080415665"},"themes":[],"title":"Investing with numbers or stories","htmlText":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","listText":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","text":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9084693844","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094785972,"gmtCreate":1645236977781,"gmtModify":1676534011910,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Noted. Thank you.&nbsp;","listText":"Noted. Thank you.&nbsp;","text":"Noted. Thank you.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094785972","repostId":"1154007444","repostType":2,"isVote":1,"tweetType":1,"viewCount":715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006371597,"gmtCreate":1641618932332,"gmtModify":1676533635546,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Great. Thanks&nbsp;","listText":"Great. Thanks&nbsp;","text":"Great. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006371597","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008017800,"gmtCreate":1641341274225,"gmtModify":1676533600745,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008017800","repostId":"2201418283","repostType":4,"repost":{"id":"2201418283","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641336421,"share":"https://ttm.financial/m/news/2201418283?lang=&edition=fundamental","pubTime":"2022-01-05 06:47","market":"us","language":"en","title":"Dow posts closing record high for 2nd day, boosted by banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2201418283","media":"Reuters","summary":"* Financial sector registers all-time closing high* Ford, GM shares rise as electric truck battle heats up* Indexes: Dow up 0.6%, S&P 500 down 0.06%, Nasdaq down 1.3%NEW YORK, Jan 4 (Reuters) - The Do","content":"<html><head></head><body><p>* Financial sector registers all-time closing high</p><p>* Ford, GM shares rise as electric truck battle heats up</p><p>* Indexes: Dow up 0.6%, S&amp;P 500 down 0.06%, Nasdaq down 1.3%</p><p>NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.</p><p>The S&amp;P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.</p><p>Economically sensitive energy, financials and industrials were the leading sectors in the S&amp;P 500, with financials eking out an all-time closing high.</p><p>Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.</p><p>Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.</p><p>The S&amp;P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.</p><p>Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.</p><p>Investors are &#34;going to punish growth stocks with high valuations,&#34; said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.</p><p>&#34;This is a time when defensive stocks and value stocks are likely to outperform.&#34;</p><p>The S&amp;P 500 value index jumped 1%, while the S&amp;P 500 growth index fell 1%.</p><p>The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&amp;P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.</p><p>The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.</p><p>Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.</p><p>Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.</p><p>Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.</p><p>General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.</p><p>Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.</p><p>Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow posts closing record high for 2nd day, boosted by banks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow posts closing record high for 2nd day, boosted by banks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-05 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Financial sector registers all-time closing high</p><p>* Ford, GM shares rise as electric truck battle heats up</p><p>* Indexes: Dow up 0.6%, S&amp;P 500 down 0.06%, Nasdaq down 1.3%</p><p>NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.</p><p>The S&amp;P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.</p><p>Economically sensitive energy, financials and industrials were the leading sectors in the S&amp;P 500, with financials eking out an all-time closing high.</p><p>Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.</p><p>Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.</p><p>The S&amp;P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.</p><p>Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.</p><p>Investors are &#34;going to punish growth stocks with high valuations,&#34; said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.</p><p>&#34;This is a time when defensive stocks and value stocks are likely to outperform.&#34;</p><p>The S&amp;P 500 value index jumped 1%, while the S&amp;P 500 growth index fell 1%.</p><p>The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&amp;P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.</p><p>The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.</p><p>Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.</p><p>Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.</p><p>Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.</p><p>General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.</p><p>Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.</p><p>Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","F":"福特汽车","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","TSLA":"特斯拉","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","GM":"通用汽车"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201418283","content_text":"* Financial sector registers all-time closing high* Ford, GM shares rise as electric truck battle heats up* Indexes: Dow up 0.6%, S&P 500 down 0.06%, Nasdaq down 1.3%NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.The S&P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.Economically sensitive energy, financials and industrials were the leading sectors in the S&P 500, with financials eking out an all-time closing high.Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.The S&P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.Investors are \"going to punish growth stocks with high valuations,\" said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.\"This is a time when defensive stocks and value stocks are likely to outperform.\"The S&P 500 value index jumped 1%, while the S&P 500 growth index fell 1%.The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.The S&P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001642576,"gmtCreate":1641252565118,"gmtModify":1676533587775,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":", 👍","listText":", 👍","text":", 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001642576","repostId":"1107989447","repostType":4,"repost":{"id":"1107989447","pubTimestamp":1641222864,"share":"https://ttm.financial/m/news/1107989447?lang=&edition=fundamental","pubTime":"2022-01-03 23:14","market":"us","language":"en","title":"10 Biggest Price Target Changes For Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1107989447","media":"Benzinga","summary":"Wells Fargo cut the price target on Ross Stores, Inc. from $135 to $120. Ross Stores shares fell 0.4","content":"<html><head></head><body><ul><li>Wells Fargo cut the price target on <b>Ross Stores, Inc.</b> from $135 to $120. Ross Stores shares fell 0.4% to $113.80 in pre-market trading.</li><li>Piper Sandler lifted <b>McDonald&#39;s Corporation</b> price target from $232 to $282. McDonald&#39;s shares rose 1.1% to $271.00 in pre-market trading.</li><li>Barclays raised the price target on <b>The PNC Financial Services Group, Inc.</b> from $220 to $250. PNC Financial shares dropped 1.8% to $196.87 in pre-market trading.</li><li>Deutsche Bank raised <b>AvalonBay Communities, Inc.</b> price target from $225 to $285. AvalonBay Communities shares rose 0.6% to $254.00 in pre-market trading.</li><li>BMO Capital cut the price target on <b>PayPal Holdings, Inc.</b> from $278 to $224. PayPal shares rose 2% to $192.30 in pre-market trading.</li><li>HC Wainwright &amp; Co. reduced <b>Arcadia Biosciences, Inc.</b> price target from $7 to $6. Arcadia Biosciences shares gained 5.8% to $1.10 in pre-market trading.</li><li>Piper Sandler reduced <b>The Cheesecake Factory Incorporated</b> price target from $65 to $44. Cheesecake Factory shares fell 1.5% to close at $39.15 on Friday.</li><li>JPMorgan raised the price target for <b>Tesla, Inc.</b> from $250 to $295. Tesla shares gained 7% to $1,131.02 in pre-market trading.</li><li>Mizuho raised the price target for <b>Exelon Corporation</b> from $55 to $57. Exelon shares rose 0.7% to close at $57.76 on Friday.</li><li>Goldman Sachs cut <b>Kingsoft Cloud Holdings Limited</b> price target from $37 to $18. Kingsoft Cloud shares fell 1.6% to $15.50 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 23:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/penny-stocks/22/01/24859965/10-biggest-price-target-changes-for-monday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wells Fargo cut the price target on Ross Stores, Inc. from $135 to $120. Ross Stores shares fell 0.4% to $113.80 in pre-market trading.Piper Sandler lifted McDonald's Corporation price target from $...</p>\n\n<a href=\"https://www.benzinga.com/markets/penny-stocks/22/01/24859965/10-biggest-price-target-changes-for-monday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MCD":"麦当劳","PYPL":"PayPal","TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/markets/penny-stocks/22/01/24859965/10-biggest-price-target-changes-for-monday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107989447","content_text":"Wells Fargo cut the price target on Ross Stores, Inc. from $135 to $120. Ross Stores shares fell 0.4% to $113.80 in pre-market trading.Piper Sandler lifted McDonald's Corporation price target from $232 to $282. McDonald's shares rose 1.1% to $271.00 in pre-market trading.Barclays raised the price target on The PNC Financial Services Group, Inc. from $220 to $250. PNC Financial shares dropped 1.8% to $196.87 in pre-market trading.Deutsche Bank raised AvalonBay Communities, Inc. price target from $225 to $285. AvalonBay Communities shares rose 0.6% to $254.00 in pre-market trading.BMO Capital cut the price target on PayPal Holdings, Inc. from $278 to $224. PayPal shares rose 2% to $192.30 in pre-market trading.HC Wainwright & Co. reduced Arcadia Biosciences, Inc. price target from $7 to $6. Arcadia Biosciences shares gained 5.8% to $1.10 in pre-market trading.Piper Sandler reduced The Cheesecake Factory Incorporated price target from $65 to $44. Cheesecake Factory shares fell 1.5% to close at $39.15 on Friday.JPMorgan raised the price target for Tesla, Inc. from $250 to $295. Tesla shares gained 7% to $1,131.02 in pre-market trading.Mizuho raised the price target for Exelon Corporation from $55 to $57. Exelon shares rose 0.7% to close at $57.76 on Friday.Goldman Sachs cut Kingsoft Cloud Holdings Limited price target from $37 to $18. Kingsoft Cloud shares fell 1.6% to $15.50 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009571966,"gmtCreate":1640743573487,"gmtModify":1676533538375,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"😂😢","listText":"😂😢","text":"😂😢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009571966","repostId":"1130537383","repostType":4,"isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893415979,"gmtCreate":1628295283391,"gmtModify":1703504590463,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893415979","repostId":"1130636428","repostType":4,"repost":{"id":"1130636428","pubTimestamp":1628256231,"share":"https://ttm.financial/m/news/1130636428?lang=&edition=fundamental","pubTime":"2021-08-06 21:23","market":"us","language":"en","title":"Apple suppliers in China reportedly struggling to find iPhone workers","url":"https://stock-news.laohu8.com/highlight/detail?id=1130636428","media":"seekingalpha","summary":"Apple suppliers in China including Foxconn(OTCPK:HNHAF)are reportedly raising their starting bonuses","content":"<p><a href=\"https://laohu8.com/S/AAPL\">Apple</a>&nbsp;suppliers in China including Foxconn(OTCPK:HNHAF)are reportedly raising their starting bonuses to attract more workers ahead of the iPhone 13 launch this fall.</p>\n<p>South China Morning <a href=\"https://laohu8.com/S/POST\">Post</a> sourcessay Foxconn has raised its new hires bonus to about $1,578 for workers who stay for at least 90 days in its integrated <a href=\"https://laohu8.com/S/DLR\">Digital</a> Product Business Group, which handles iPhone assembly. Foxconn had previously raised the bonus on July 23.</p>\n<p>China houses more Apple (AAPL) suppliers than any other country and the region is reportedly experiencing a shortage of young people who want to work in manufacturing.</p>\n<p>Last week, Apple (AAPL) reported upside earnings driven by strong iPhone sales. CEO Tim Cook warned that the global supply chain constraints will likely have a negative sales impact on thesmartphones in the current quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple suppliers in China reportedly struggling to find iPhone workers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple suppliers in China reportedly struggling to find iPhone workers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3727007-apple-suppliers-in-china-reportedly-struggling-to-find-iphone-workers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple suppliers in China including Foxconn(OTCPK:HNHAF)are reportedly raising their starting bonuses to attract more workers ahead of the iPhone 13 launch this fall.\nSouth China Morning Post ...</p>\n\n<a href=\"https://seekingalpha.com/news/3727007-apple-suppliers-in-china-reportedly-struggling-to-find-iphone-workers\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03086":"华夏纳指","09086":"华夏纳指-U","AAPL":"苹果"},"source_url":"https://seekingalpha.com/news/3727007-apple-suppliers-in-china-reportedly-struggling-to-find-iphone-workers","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1130636428","content_text":"Apple suppliers in China including Foxconn(OTCPK:HNHAF)are reportedly raising their starting bonuses to attract more workers ahead of the iPhone 13 launch this fall.\nSouth China Morning Post sourcessay Foxconn has raised its new hires bonus to about $1,578 for workers who stay for at least 90 days in its integrated Digital Product Business Group, which handles iPhone assembly. Foxconn had previously raised the bonus on July 23.\nChina houses more Apple (AAPL) suppliers than any other country and the region is reportedly experiencing a shortage of young people who want to work in manufacturing.\nLast week, Apple (AAPL) reported upside earnings driven by strong iPhone sales. CEO Tim Cook warned that the global supply chain constraints will likely have a negative sales impact on thesmartphones in the current quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804155873,"gmtCreate":1627947313592,"gmtModify":1703498219056,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804155873","repostId":"2156116807","repostType":4,"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159493779,"gmtCreate":1624976046591,"gmtModify":1703849286179,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159493779","repostId":"1150529415","repostType":4,"repost":{"id":"1150529415","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624973992,"share":"https://ttm.financial/m/news/1150529415?lang=&edition=fundamental","pubTime":"2021-06-29 21:39","market":"us","language":"en","title":"Crypto stocks strengthen with bitcoin","url":"https://stock-news.laohu8.com/highlight/detail?id=1150529415","media":"Tiger Newspress","summary":"Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first t","content":"<p>Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon&nbsp;Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital&nbsp;and&nbsp;Square&nbsp;climbed between 2% and 10%.</p>\n<p><img src=\"https://static.tigerbbs.com/a4dab206c84d9e5f82c395a1b2a79c54\" tg-width=\"354\" tg-height=\"720\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto stocks strengthen with bitcoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto stocks strengthen with bitcoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-29 21:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon&nbsp;Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital&nbsp;and&nbsp;Square&nbsp;climbed between 2% and 10%.</p>\n<p><img src=\"https://static.tigerbbs.com/a4dab206c84d9e5f82c395a1b2a79c54\" tg-width=\"354\" tg-height=\"720\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150529415","content_text":"Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital and Square climbed between 2% and 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159543414,"gmtCreate":1624975358638,"gmtModify":1703849243949,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159543414","repostId":"2146388793","repostType":4,"repost":{"id":"2146388793","pubTimestamp":1624959775,"share":"https://ttm.financial/m/news/2146388793?lang=&edition=fundamental","pubTime":"2021-06-29 17:42","market":"us","language":"en","title":"2 Robinhood Stocks That Could Crush Dogecoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2146388793","media":"Motley Fool","summary":"They're already big winners but could have much more room to run.","content":"<p><b>Dogecoin</b> (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.</p>\n<p>On the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.</p>\n<p>Regardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/21859b0af15cb96a0c3a3aa3d6358251\" tg-width=\"700\" tg-height=\"420\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>NVIDIA</h2>\n<p>While Dogecoin has nosedived in recent months, <b>NVIDIA</b> (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-<a href=\"https://laohu8.com/S/AONE\">one</a> stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.</p>\n<p>However, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.</p>\n<p>Gaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.</p>\n<p>It isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).</p>\n<p>I especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).</p>\n<p>NVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.</p>\n<p>Don't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).</p>\n<p>Assuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.</p>\n<p>Sure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.</p>\n<h2>Moderna</h2>\n<p>Most companies can't honestly say that they've helped change the world.&nbsp;<b>Moderna</b> (NASDAQ:MRNA) can.</p>\n<p>The biotech's COVID-19 vaccine was second only to the vaccine developed by <b>Pfizer</b>&nbsp;and <b>BioNTech</b> to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.</p>\n<p>Based on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.</p>\n<p>In just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.</p>\n<p>But does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.</p>\n<p>The big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.</p>\n<p>Then there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.</p>\n<p>Moderna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.</p>\n<p>All of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Robinhood Stocks That Could Crush Dogecoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Robinhood Stocks That Could Crush Dogecoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 17:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146388793","content_text":"Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.\nOn the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.\nRegardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.\nImage source: Getty Images.\nNVIDIA\nWhile Dogecoin has nosedived in recent months, NVIDIA (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-one stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.\nHowever, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.\nGaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.\nIt isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).\nI especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).\nNVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.\nDon't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).\nAssuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.\nSure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.\nModerna\nMost companies can't honestly say that they've helped change the world. Moderna (NASDAQ:MRNA) can.\nThe biotech's COVID-19 vaccine was second only to the vaccine developed by Pfizer and BioNTech to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.\nBased on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.\nIn just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.\nBut does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.\nThe big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.\nThen there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.\nModerna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.\nAll of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":804155873,"gmtCreate":1627947313592,"gmtModify":1703498219056,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804155873","repostId":"2156116807","repostType":4,"repost":{"id":"2156116807","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627915046,"share":"https://ttm.financial/m/news/2156116807?lang=&edition=fundamental","pubTime":"2021-08-02 22:37","market":"us","language":"en","title":"Wall Street avoids delta anxiety to push stocks near record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2156116807","media":"Reuters","summary":"BOSTON, Aug 2 (Reuters) - U.S. stocks rose in early trading Monday morning on optimism over governme","content":"<p>BOSTON, Aug 2 (Reuters) - U.S. stocks rose in early trading Monday morning on optimism over government infrastructure spending and strong corporate earnings, even as oil prices fell on broader macroeconomic fear and the spread of the delta variant of the coronavirus continued.</p>\n<p>U.S. senators on Sunday unveiled a bipartisan plan to invest around $1 trillion in roads, bridges, ports, high-speed internet and other infrastructure, with some predicting the spending bill, the largest in decades, could pass as early as this week.</p>\n<p>A rebound in corporate profits and the recent drop in bond yields are also bolstering the case for owning stocks, even as markets stand near records and economic growth is expected to slow.</p>\n<p>Those factors helped push the S&amp;P 500 index to a near all-time high on Monday, up 20.77 points, or 0.47%, to 4,416.03.</p>\n<p>The Dow Jones Industrial Average rose 238.94 points, or 0.68%, to 35,174.41, and the Nasdaq Composite added 20.90 points, or 0.14%, to 14,693.58.</p>\n<p>The MSCI world equity index , which tracks shares in 49 countries, gained 0.65%.</p>\n<p>At the same time, oil prices fell on Monday as worries over China's economy resurfaced after a survey showing growth in factory activity slipped sharply in the world's second-largest oil consumer, with concerns compounded by higher crude output from OPEC producers.</p>\n<p>U.S. crude recently fell 0.96% to $73.24 per barrel and Brent was at $74.77, down 0.85% on the day.</p>\n<p>Market attention now turns to U.S. manufacturing activity data for July, as well as the Reserve Bank of Australia meeting on Tuesday, the Bank of England meeting on Thursday, and U.S. payrolls data on Friday.</p>\n<p>Factories across the world are suffering from supply bottlenecks, which sent prices skyrocketing in July, while a new wave of coronavirus infections in Asia demonstrated the fragile nature of the global recovery.</p>\n<p>The 10-year U.S. Treasury yield was at 1.2172%, little changed on the day but having seen a gradual decline since April.</p>\n<p>Negatively interpreting lower Treasury yields could be a mistake, according to <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> strategist Guneet Dhingra.</p>\n<p>\"Investors are fitting a narrative of excessive pessimism to lower yields,\" Dhingra wrote in a note Sunday.</p>\n<p>\"Many of these narratives don’t stand up to scrutiny,\" Dhingra said, noting low hospitalizations in the UK from the Delta variant as a model for the United States, \"suggesting overstated downside risks from COVID-19.\"</p>\n<p>The dollar fell back towards the <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month lows hit last week when it became clear the Fed was in no hurry to tighten policy.</p>\n<p>As of mid-morning Monday, the dollar index was down 0.142%, with the euro up 0.1% at $1.1882.</p>\n<p>(Reporting by Lawrence Delevingne and Elizabeth Howcroft; Editing by Steve Orlofsky)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street avoids delta anxiety to push stocks near record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street avoids delta anxiety to push stocks near record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-02 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BOSTON, Aug 2 (Reuters) - U.S. stocks rose in early trading Monday morning on optimism over government infrastructure spending and strong corporate earnings, even as oil prices fell on broader macroeconomic fear and the spread of the delta variant of the coronavirus continued.</p>\n<p>U.S. senators on Sunday unveiled a bipartisan plan to invest around $1 trillion in roads, bridges, ports, high-speed internet and other infrastructure, with some predicting the spending bill, the largest in decades, could pass as early as this week.</p>\n<p>A rebound in corporate profits and the recent drop in bond yields are also bolstering the case for owning stocks, even as markets stand near records and economic growth is expected to slow.</p>\n<p>Those factors helped push the S&amp;P 500 index to a near all-time high on Monday, up 20.77 points, or 0.47%, to 4,416.03.</p>\n<p>The Dow Jones Industrial Average rose 238.94 points, or 0.68%, to 35,174.41, and the Nasdaq Composite added 20.90 points, or 0.14%, to 14,693.58.</p>\n<p>The MSCI world equity index , which tracks shares in 49 countries, gained 0.65%.</p>\n<p>At the same time, oil prices fell on Monday as worries over China's economy resurfaced after a survey showing growth in factory activity slipped sharply in the world's second-largest oil consumer, with concerns compounded by higher crude output from OPEC producers.</p>\n<p>U.S. crude recently fell 0.96% to $73.24 per barrel and Brent was at $74.77, down 0.85% on the day.</p>\n<p>Market attention now turns to U.S. manufacturing activity data for July, as well as the Reserve Bank of Australia meeting on Tuesday, the Bank of England meeting on Thursday, and U.S. payrolls data on Friday.</p>\n<p>Factories across the world are suffering from supply bottlenecks, which sent prices skyrocketing in July, while a new wave of coronavirus infections in Asia demonstrated the fragile nature of the global recovery.</p>\n<p>The 10-year U.S. Treasury yield was at 1.2172%, little changed on the day but having seen a gradual decline since April.</p>\n<p>Negatively interpreting lower Treasury yields could be a mistake, according to <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> strategist Guneet Dhingra.</p>\n<p>\"Investors are fitting a narrative of excessive pessimism to lower yields,\" Dhingra wrote in a note Sunday.</p>\n<p>\"Many of these narratives don’t stand up to scrutiny,\" Dhingra said, noting low hospitalizations in the UK from the Delta variant as a model for the United States, \"suggesting overstated downside risks from COVID-19.\"</p>\n<p>The dollar fell back towards the <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month lows hit last week when it became clear the Fed was in no hurry to tighten policy.</p>\n<p>As of mid-morning Monday, the dollar index was down 0.142%, with the euro up 0.1% at $1.1882.</p>\n<p>(Reporting by Lawrence Delevingne and Elizabeth Howcroft; Editing by Steve Orlofsky)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","DDG":"ProShares做空石油与天然气ETF","QLD":"纳指两倍做多ETF","UCO":"二倍做多彭博原油ETF","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","SCO":"二倍做空彭博原油指数ETF","USO":"美国原油ETF","QQQ":"纳指100ETF","DUG":"二倍做空石油与天然气ETF(ProShares)","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","DDM":"道指两倍做多ETF","DWT":"三倍做空原油ETN","TQQQ":"纳指三倍做多ETF","DOG":"道指反向ETF","UDOW":"道指三倍做多ETF-ProShares","SDOW":"道指三倍做空ETF-ProShares","PSQ":"纳指反向ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156116807","content_text":"BOSTON, Aug 2 (Reuters) - U.S. stocks rose in early trading Monday morning on optimism over government infrastructure spending and strong corporate earnings, even as oil prices fell on broader macroeconomic fear and the spread of the delta variant of the coronavirus continued.\nU.S. senators on Sunday unveiled a bipartisan plan to invest around $1 trillion in roads, bridges, ports, high-speed internet and other infrastructure, with some predicting the spending bill, the largest in decades, could pass as early as this week.\nA rebound in corporate profits and the recent drop in bond yields are also bolstering the case for owning stocks, even as markets stand near records and economic growth is expected to slow.\nThose factors helped push the S&P 500 index to a near all-time high on Monday, up 20.77 points, or 0.47%, to 4,416.03.\nThe Dow Jones Industrial Average rose 238.94 points, or 0.68%, to 35,174.41, and the Nasdaq Composite added 20.90 points, or 0.14%, to 14,693.58.\nThe MSCI world equity index , which tracks shares in 49 countries, gained 0.65%.\nAt the same time, oil prices fell on Monday as worries over China's economy resurfaced after a survey showing growth in factory activity slipped sharply in the world's second-largest oil consumer, with concerns compounded by higher crude output from OPEC producers.\nU.S. crude recently fell 0.96% to $73.24 per barrel and Brent was at $74.77, down 0.85% on the day.\nMarket attention now turns to U.S. manufacturing activity data for July, as well as the Reserve Bank of Australia meeting on Tuesday, the Bank of England meeting on Thursday, and U.S. payrolls data on Friday.\nFactories across the world are suffering from supply bottlenecks, which sent prices skyrocketing in July, while a new wave of coronavirus infections in Asia demonstrated the fragile nature of the global recovery.\nThe 10-year U.S. Treasury yield was at 1.2172%, little changed on the day but having seen a gradual decline since April.\nNegatively interpreting lower Treasury yields could be a mistake, according to Morgan Stanley strategist Guneet Dhingra.\n\"Investors are fitting a narrative of excessive pessimism to lower yields,\" Dhingra wrote in a note Sunday.\n\"Many of these narratives don’t stand up to scrutiny,\" Dhingra said, noting low hospitalizations in the UK from the Delta variant as a model for the United States, \"suggesting overstated downside risks from COVID-19.\"\nThe dollar fell back towards the one-month lows hit last week when it became clear the Fed was in no hurry to tighten policy.\nAs of mid-morning Monday, the dollar index was down 0.142%, with the euro up 0.1% at $1.1882.\n(Reporting by Lawrence Delevingne and Elizabeth Howcroft; Editing by Steve Orlofsky)","news_type":1},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006371597,"gmtCreate":1641618932332,"gmtModify":1676533635546,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Great. Thanks&nbsp;","listText":"Great. Thanks&nbsp;","text":"Great. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006371597","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009571966,"gmtCreate":1640743573487,"gmtModify":1676533538375,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"😂😢","listText":"😂😢","text":"😂😢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009571966","repostId":"1130537383","repostType":4,"repost":{"id":"1130537383","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640742775,"share":"https://ttm.financial/m/news/1130537383?lang=&edition=fundamental","pubTime":"2021-12-29 09:52","market":"us","language":"en","title":"Elon Musk Sells $1.02 Billion Worth of Tesla Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1130537383","media":"Tiger Newspress","summary":"Elon Musk sold $1.02 billion of Tesla Inc. shares, according to a filing with the U.S. Securities & ","content":"<p>Elon Musk sold $1.02 billion of Tesla Inc. shares, according to a filing with the U.S. Securities &amp; Exchange Commission.</p>\n<p>The Tesla chief executive officer sold 934,090 shares, the filing showed.</p>\n<p>Musk, the world’s richest person, has been offloading Tesla stock since asking his Twitter followers in November whether he should sell some of his stake.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Sells $1.02 Billion Worth of Tesla Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Sells $1.02 Billion Worth of Tesla Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-29 09:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Elon Musk sold $1.02 billion of Tesla Inc. shares, according to a filing with the U.S. Securities &amp; Exchange Commission.</p>\n<p>The Tesla chief executive officer sold 934,090 shares, the filing showed.</p>\n<p>Musk, the world’s richest person, has been offloading Tesla stock since asking his Twitter followers in November whether he should sell some of his stake.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130537383","content_text":"Elon Musk sold $1.02 billion of Tesla Inc. shares, according to a filing with the U.S. Securities & Exchange Commission.\nThe Tesla chief executive officer sold 934,090 shares, the filing showed.\nMusk, the world’s richest person, has been offloading Tesla stock since asking his Twitter followers in November whether he should sell some of his stake.","news_type":1},"isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893415979,"gmtCreate":1628295283391,"gmtModify":1703504590463,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893415979","repostId":"1130636428","repostType":4,"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159493779,"gmtCreate":1624976046591,"gmtModify":1703849286179,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159493779","repostId":"1150529415","repostType":4,"repost":{"id":"1150529415","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624973992,"share":"https://ttm.financial/m/news/1150529415?lang=&edition=fundamental","pubTime":"2021-06-29 21:39","market":"us","language":"en","title":"Crypto stocks strengthen with bitcoin","url":"https://stock-news.laohu8.com/highlight/detail?id=1150529415","media":"Tiger Newspress","summary":"Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first t","content":"<p>Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon&nbsp;Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital&nbsp;and&nbsp;Square&nbsp;climbed between 2% and 10%.</p>\n<p><img src=\"https://static.tigerbbs.com/a4dab206c84d9e5f82c395a1b2a79c54\" tg-width=\"354\" tg-height=\"720\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto stocks strengthen with bitcoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto stocks strengthen with bitcoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-29 21:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon&nbsp;Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital&nbsp;and&nbsp;Square&nbsp;climbed between 2% and 10%.</p>\n<p><img src=\"https://static.tigerbbs.com/a4dab206c84d9e5f82c395a1b2a79c54\" tg-width=\"354\" tg-height=\"720\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150529415","content_text":"Crypto stocks strengthen with bitcoin.Bitcoin station on 36000 U.S. dollars / piece, for the first time since June 21, the day up 4.39%.Marathon Digital,Riot Blockchain,Canaan,The9,Coinbase,SOS Ltd.,Big Digital and Square climbed between 2% and 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159543414,"gmtCreate":1624975358638,"gmtModify":1703849243949,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159543414","repostId":"2146388793","repostType":4,"repost":{"id":"2146388793","pubTimestamp":1624959775,"share":"https://ttm.financial/m/news/2146388793?lang=&edition=fundamental","pubTime":"2021-06-29 17:42","market":"us","language":"en","title":"2 Robinhood Stocks That Could Crush Dogecoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2146388793","media":"Motley Fool","summary":"They're already big winners but could have much more room to run.","content":"<p><b>Dogecoin</b> (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.</p>\n<p>On the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.</p>\n<p>Regardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/21859b0af15cb96a0c3a3aa3d6358251\" tg-width=\"700\" tg-height=\"420\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>NVIDIA</h2>\n<p>While Dogecoin has nosedived in recent months, <b>NVIDIA</b> (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-<a href=\"https://laohu8.com/S/AONE\">one</a> stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.</p>\n<p>However, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.</p>\n<p>Gaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.</p>\n<p>It isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).</p>\n<p>I especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).</p>\n<p>NVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.</p>\n<p>Don't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).</p>\n<p>Assuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.</p>\n<p>Sure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.</p>\n<h2>Moderna</h2>\n<p>Most companies can't honestly say that they've helped change the world.&nbsp;<b>Moderna</b> (NASDAQ:MRNA) can.</p>\n<p>The biotech's COVID-19 vaccine was second only to the vaccine developed by <b>Pfizer</b>&nbsp;and <b>BioNTech</b> to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.</p>\n<p>Based on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.</p>\n<p>In just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.</p>\n<p>But does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.</p>\n<p>The big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.</p>\n<p>Then there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.</p>\n<p>Moderna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.</p>\n<p>All of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Robinhood Stocks That Could Crush Dogecoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Robinhood Stocks That Could Crush Dogecoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 17:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146388793","content_text":"Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.\nOn the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.\nRegardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.\nImage source: Getty Images.\nNVIDIA\nWhile Dogecoin has nosedived in recent months, NVIDIA (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-one stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.\nHowever, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.\nGaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.\nIt isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).\nI especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).\nNVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.\nDon't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).\nAssuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.\nSure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.\nModerna\nMost companies can't honestly say that they've helped change the world. Moderna (NASDAQ:MRNA) can.\nThe biotech's COVID-19 vaccine was second only to the vaccine developed by Pfizer and BioNTech to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.\nBased on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.\nIn just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.\nBut does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.\nThe big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.\nThen there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.\nModerna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.\nAll of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001642576,"gmtCreate":1641252565118,"gmtModify":1676533587775,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":", 👍","listText":", 👍","text":", 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001642576","repostId":"1107989447","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008017800,"gmtCreate":1641341274225,"gmtModify":1676533600745,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008017800","repostId":"2201418283","repostType":4,"repost":{"id":"2201418283","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641336421,"share":"https://ttm.financial/m/news/2201418283?lang=&edition=fundamental","pubTime":"2022-01-05 06:47","market":"us","language":"en","title":"Dow posts closing record high for 2nd day, boosted by banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2201418283","media":"Reuters","summary":"* Financial sector registers all-time closing high* Ford, GM shares rise as electric truck battle heats up* Indexes: Dow up 0.6%, S&P 500 down 0.06%, Nasdaq down 1.3%NEW YORK, Jan 4 (Reuters) - The Do","content":"<html><head></head><body><p>* Financial sector registers all-time closing high</p><p>* Ford, GM shares rise as electric truck battle heats up</p><p>* Indexes: Dow up 0.6%, S&amp;P 500 down 0.06%, Nasdaq down 1.3%</p><p>NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.</p><p>The S&amp;P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.</p><p>Economically sensitive energy, financials and industrials were the leading sectors in the S&amp;P 500, with financials eking out an all-time closing high.</p><p>Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.</p><p>Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.</p><p>The S&amp;P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.</p><p>Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.</p><p>Investors are &#34;going to punish growth stocks with high valuations,&#34; said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.</p><p>&#34;This is a time when defensive stocks and value stocks are likely to outperform.&#34;</p><p>The S&amp;P 500 value index jumped 1%, while the S&amp;P 500 growth index fell 1%.</p><p>The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&amp;P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.</p><p>The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.</p><p>Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.</p><p>Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.</p><p>Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.</p><p>General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.</p><p>Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.</p><p>Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow posts closing record high for 2nd day, boosted by banks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow posts closing record high for 2nd day, boosted by banks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-05 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Financial sector registers all-time closing high</p><p>* Ford, GM shares rise as electric truck battle heats up</p><p>* Indexes: Dow up 0.6%, S&amp;P 500 down 0.06%, Nasdaq down 1.3%</p><p>NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.</p><p>The S&amp;P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.</p><p>Economically sensitive energy, financials and industrials were the leading sectors in the S&amp;P 500, with financials eking out an all-time closing high.</p><p>Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.</p><p>Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.</p><p>The S&amp;P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.</p><p>Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.</p><p>Investors are &#34;going to punish growth stocks with high valuations,&#34; said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.</p><p>&#34;This is a time when defensive stocks and value stocks are likely to outperform.&#34;</p><p>The S&amp;P 500 value index jumped 1%, while the S&amp;P 500 growth index fell 1%.</p><p>The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&amp;P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.</p><p>The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.</p><p>Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.</p><p>Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.</p><p>Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.</p><p>General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.</p><p>Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.</p><p>Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","F":"福特汽车","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","TSLA":"特斯拉","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","GM":"通用汽车"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201418283","content_text":"* Financial sector registers all-time closing high* Ford, GM shares rise as electric truck battle heats up* Indexes: Dow up 0.6%, S&P 500 down 0.06%, Nasdaq down 1.3%NEW YORK, Jan 4 (Reuters) - The Dow Jones Industrial Average reached a record closing high on Tuesday for a second straight day as financial and industrial shares rallied, while the Nasdaq fell.The S&P 500 ended slightly weaker after hitting an intraday all-time high. Declines in shares of big growth names including Tesla Inc weighed on the index and the Nasdaq Composite, which ended down more than 1%.Economically sensitive energy, financials and industrials were the leading sectors in the S&P 500, with financials eking out an all-time closing high.Helping sentiment, the World Health Organization cited increasing evidence that the coronavirus variant caused milder symptoms than previous variants.Earlier, U.S. manufacturing data for December showed some cooling in demand for goods, but investors took solace in signs of supply constraints easing.The S&P 500 bank index rose 3.5% in its biggest daily percentage gain in about a year.Some strategists said financials and other value-oriented stocks could be near-term market leaders as investors gear up for interest rate hikes from the Federal Reserve by mid-year to curb high inflation. U.S. Treasury yields gained for a second trading day.Investors are \"going to punish growth stocks with high valuations,\" said Robert Phipps, a director at Per Stirling Capital Management in Austin, Texas.\"This is a time when defensive stocks and value stocks are likely to outperform.\"The S&P 500 value index jumped 1%, while the S&P 500 growth index fell 1%.The Dow Jones Industrial Average rose 214.59 points, or 0.59%, to 36,799.65; the S&P 500 lost 3.02 points, or 0.06%, at 4,793.54; and the Nasdaq Composite dropped 210.08 points, or 1.33%, to 15,622.72.The U.S. central bank said last month it would end its pandemic-era bond buying in 2022, signaling at least three interest rate hikes for the year. Minutes from the meeting are expected to be released on Wednesday.Daniel Morgan, portfolio manager at Synovus Trust in Atlanta, said he still favored technology and growth shares, and was optimistic that fourth-quarter earnings for tech and the chip sector in particular could be stronger than Wall Street expectations.Tesla shares fell 4.2%, a day after jumping more than 13% on stronger-than-expected quarterly deliveries.Ford Motor Co jumped 11.7% after the automaker said it would nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles.General Motors Co shares rallied 7.5% a day ahead of its public debut of the Chevrolet Silverado electric pickup, which is slated to go on sale in early 2023.Advancing issues outnumbered decliners on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.44-to-1 ratio favored decliners.The S&P 500 posted 70 new 52-week highs and one new low; the Nasdaq Composite recorded 104 new highs and 102 new lows.Volume on U.S. exchanges was 11.49 billion shares, compared with about 10.4 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9998177903,"gmtCreate":1660960425205,"gmtModify":1676536430704,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Noted with thanks.&nbsp;","listText":"Noted with thanks.&nbsp;","text":"Noted with thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9998177903","repostId":"1133089120","repostType":4,"repost":{"id":"1133089120","pubTimestamp":1660957054,"share":"https://ttm.financial/m/news/1133089120?lang=&edition=fundamental","pubTime":"2022-08-20 08:57","market":"sg","language":"en","title":"These 4 Singapore Stocks are Trading at a 52-Week Low: Are They a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=1133089120","media":"The Smart Investor","summary":"Investors who are scouring the bargain bin for cheap stocks can turn their attention to these four c","content":"<html><head></head><body><p>Investors who are scouring the bargain bin for cheap stocks can turn their attention to these four companies.</p><p><img src=\"https://static.tigerbbs.com/9833467a6ad6d0507aa473f862a2e27f\" tg-width=\"800\" tg-height=\"533\" width=\"100%\" height=\"auto\"/></p><p>Investors love a great bargain in the stock market.</p><p>The market sometimes provides us with a Great Singapore Sale where we can buy stocks on the cheap.</p><p>By doing so, we increase the chances of obtaining a favourable outcome in the long run.</p><p>That said, it pays to be wary of value traps.</p><p>Some companies are hitting a low because their business may be floundering or they may have temporarily hit a rough patch.</p><p>It’s important to tell these two scenarios apart as the former will cause more heartache but the latter represents a great opportunity to accumulate.</p><p>Here are four Singapore stocks that recently hit their 52-week lows.</p><p>We provide the facts but you need to decide if these stocks may be suitable for your portfolio.</p><p><b>Keppel Pacific Oak US REIT (SGX: CMOU)</b></p><p>Keppel Pacific Oak US REIT, or KORE, invests in commercial assets in key growth markets in the US.</p><p>Its portfolio comprises 15 freehold office buildings and business campuses across nine US states with a total asset value of US$1.45 billion as of 30 June 2022.</p><p>KORE’s share price has tumbled around 18% year to date and has hit a 52-week low of US$0.66.</p><p>The office REIT reported a steady set of earnings for its fiscal 2022’s first half (1H2022).</p><p>Gross revenue rose 8.4% year on year to US$74.1 million while net property income (NPI) increased by 5.9% year on year to US$43 million.</p><p>Distributio nper unit (DPU), however, fell by 4.4% year on year to US$0.0302, with part of the reason being that the manager’s base fee for the second quarter is being paid entirely in cash rather than in units of KORE.</p><p>The REIT maintains a high portfolio committed occupancy of 92%.</p><p>Its aggregate leverage stands at 37.2% with an all-in average cost of debt of 2.88%. 77.1% of the KORE’s total borrowings are on fixed rates.</p><p>However, if the borrowings are refinanced, the average cost of debt will rise to 3.15%.</p><p><b>Manulife US REIT (SGX: BTOU)</b></p><p>Manulife US REIT, or MUST, owns a portfolio of 12 freehold office properties in the US valued at around US$2.2 billion as of 31 December 2021.</p><p>The commercial REIT has seen its unit price tumble 20.9% year to date to a 52-week low of US$0.53.</p><p>1H2022 saw gross revenue rise 10.6% year on year to US$100.4 million while NPI inched up 2.8% year on year to US$57.6 million.</p><p>DPU dipped by 3.3% year on year to US$0.0261.</p><p>MUST reported 90% occupancy for its portfolio but physical occupancy only came in at around 28%.</p><p>The commercial REIT’s gearing is on the high side at 42.4% as of 30 June 2022 but more than 85% of its loans are on fixed rates.</p><p>Around 96% of MUST’s portfolio has rental escalations incorporated into its tenancy agreements that should see a 2.2% per annum uplift in rental income.</p><p><b>Yangzijiang Financial Holding Ltd (SGX: YF8)</b></p><p>Yangzijiang Financial, or YZJF, is an investment management company that invests in public and private companies, debt investments, and funds.</p><p>The group also provides wealth management services to clients and generates fee-based income through fund management activities.</p><p>Since it was spun off from parent <b>Yangzijiang Shipbuilding Holdings Ltd</b> (SGX: BS6) back in April, its share price has tumbled 43% to a 52-week low of S$0.35.</p><p>YZJF reported a 27.3% year on year fall in total income to S$173.8 million due to a fall in the fair values of financial assets that it holds.</p><p>Net profit tumbled by 30.6% year on year to S$136.4 million.</p><p>As of 30 June, close to 90% of YZJF’s investments are in China, with the remainder parked in Singapore.</p><p>The group’s medium-term target is to reduce its debt investment in China from the current 70% to just 30% while increasing its investment proportion in Singapore to around half of the portfolio.</p><p><b>Top Glove Corporation Berhad (SGX: BVA)</b></p><p>Top Glove is the world’s largest manufacturer of gloves with 49 factories capable of producing 100 billion pieces per annum as of 9 June 2022.</p><p>The group exports to more than 195 countries worldwide and employs 22,000 staff.</p><p>Top Glove’s share price has weakened by nearly 68% this year, falling from S$0.78 to a 52-week low of S$0.25.</p><p>For the first nine months of fiscal 2022 (9M2022) ended 31 May, Top Glove saw its revenue plummet 68.5% year on year to RM 4.5 billion as glove demand normalised with higher global vaccination rates.</p><p>Net profit plunged by 96% year on year to RM 288.6 million.</p><p>Average selling prices continued to decline but at a slower pace, and the poor results were due to the inability of the group to fully pass on higher costs.</p><p>In light of lower demand, Top Glove is deferred and reducing capital expenditure in the near term until the glove oversupply situation eases.</p></body></html>","source":"lsy1602567310727","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Singapore Stocks are Trading at a 52-Week Low: Are They a Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Singapore Stocks are Trading at a 52-Week Low: Are They a Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-20 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thesmartinvestor.com.sg/these-4-singapore-stocks-are-trading-at-a-52-week-low-are-they-a-buy/><strong>The Smart Investor</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors who are scouring the bargain bin for cheap stocks can turn their attention to these four companies.Investors love a great bargain in the stock market.The market sometimes provides us with a ...</p>\n\n<a href=\"https://thesmartinvestor.com.sg/these-4-singapore-stocks-are-trading-at-a-52-week-low-are-they-a-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BVA.SI":"顶级手套有限公司","YF8.SI":"YZJ Fin Hldg","CMOU.SI":"吉宝-KBS美国房地产信托","BTOU.SI":"宏利美国房地产投资信托"},"source_url":"https://thesmartinvestor.com.sg/these-4-singapore-stocks-are-trading-at-a-52-week-low-are-they-a-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133089120","content_text":"Investors who are scouring the bargain bin for cheap stocks can turn their attention to these four companies.Investors love a great bargain in the stock market.The market sometimes provides us with a Great Singapore Sale where we can buy stocks on the cheap.By doing so, we increase the chances of obtaining a favourable outcome in the long run.That said, it pays to be wary of value traps.Some companies are hitting a low because their business may be floundering or they may have temporarily hit a rough patch.It’s important to tell these two scenarios apart as the former will cause more heartache but the latter represents a great opportunity to accumulate.Here are four Singapore stocks that recently hit their 52-week lows.We provide the facts but you need to decide if these stocks may be suitable for your portfolio.Keppel Pacific Oak US REIT (SGX: CMOU)Keppel Pacific Oak US REIT, or KORE, invests in commercial assets in key growth markets in the US.Its portfolio comprises 15 freehold office buildings and business campuses across nine US states with a total asset value of US$1.45 billion as of 30 June 2022.KORE’s share price has tumbled around 18% year to date and has hit a 52-week low of US$0.66.The office REIT reported a steady set of earnings for its fiscal 2022’s first half (1H2022).Gross revenue rose 8.4% year on year to US$74.1 million while net property income (NPI) increased by 5.9% year on year to US$43 million.Distributio nper unit (DPU), however, fell by 4.4% year on year to US$0.0302, with part of the reason being that the manager’s base fee for the second quarter is being paid entirely in cash rather than in units of KORE.The REIT maintains a high portfolio committed occupancy of 92%.Its aggregate leverage stands at 37.2% with an all-in average cost of debt of 2.88%. 77.1% of the KORE’s total borrowings are on fixed rates.However, if the borrowings are refinanced, the average cost of debt will rise to 3.15%.Manulife US REIT (SGX: BTOU)Manulife US REIT, or MUST, owns a portfolio of 12 freehold office properties in the US valued at around US$2.2 billion as of 31 December 2021.The commercial REIT has seen its unit price tumble 20.9% year to date to a 52-week low of US$0.53.1H2022 saw gross revenue rise 10.6% year on year to US$100.4 million while NPI inched up 2.8% year on year to US$57.6 million.DPU dipped by 3.3% year on year to US$0.0261.MUST reported 90% occupancy for its portfolio but physical occupancy only came in at around 28%.The commercial REIT’s gearing is on the high side at 42.4% as of 30 June 2022 but more than 85% of its loans are on fixed rates.Around 96% of MUST’s portfolio has rental escalations incorporated into its tenancy agreements that should see a 2.2% per annum uplift in rental income.Yangzijiang Financial Holding Ltd (SGX: YF8)Yangzijiang Financial, or YZJF, is an investment management company that invests in public and private companies, debt investments, and funds.The group also provides wealth management services to clients and generates fee-based income through fund management activities.Since it was spun off from parent Yangzijiang Shipbuilding Holdings Ltd (SGX: BS6) back in April, its share price has tumbled 43% to a 52-week low of S$0.35.YZJF reported a 27.3% year on year fall in total income to S$173.8 million due to a fall in the fair values of financial assets that it holds.Net profit tumbled by 30.6% year on year to S$136.4 million.As of 30 June, close to 90% of YZJF’s investments are in China, with the remainder parked in Singapore.The group’s medium-term target is to reduce its debt investment in China from the current 70% to just 30% while increasing its investment proportion in Singapore to around half of the portfolio.Top Glove Corporation Berhad (SGX: BVA)Top Glove is the world’s largest manufacturer of gloves with 49 factories capable of producing 100 billion pieces per annum as of 9 June 2022.The group exports to more than 195 countries worldwide and employs 22,000 staff.Top Glove’s share price has weakened by nearly 68% this year, falling from S$0.78 to a 52-week low of S$0.25.For the first nine months of fiscal 2022 (9M2022) ended 31 May, Top Glove saw its revenue plummet 68.5% year on year to RM 4.5 billion as glove demand normalised with higher global vaccination rates.Net profit plunged by 96% year on year to RM 288.6 million.Average selling prices continued to decline but at a slower pace, and the poor results were due to the inability of the group to fully pass on higher costs.In light of lower demand, Top Glove is deferred and reducing capital expenditure in the near term until the glove oversupply situation eases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9087999050,"gmtCreate":1650936800470,"gmtModify":1676534819379,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9087999050","repostId":"9084693844","repostType":1,"repost":{"id":9084693844,"gmtCreate":1650852645978,"gmtModify":1676534803608,"author":{"id":"3558908080415665","authorId":"3558908080415665","name":"Alvin Chow","avatar":"https://static.tigerbbs.com/2abf7014742f3e282e9781e945db75b0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558908080415665","authorIdStr":"3558908080415665"},"themes":[],"title":"Investing with numbers or stories","htmlText":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","listText":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","text":"Some investors swear by using a quantitative approach to investing while others believe that numbers are less important when compared to qualitative analysis.Each has its valid concerns. The quants believe that humans are full of biases and it is not possible to overcome them easily unless one is to makae investment decisions based on numbers alone. But to the qualitative tribe, they believe that numbers are historical and not predictive of the future. You need to make a judgement call on how the future will turn out in order to make a good investment decision today.Whenever you see conflicting views online, it is important to know the context that they are making those views. Otherwise you will feel lost and confused or worse, adopt a view and apply it in a wrong context.Allow me to shed","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9084693844","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094785972,"gmtCreate":1645236977781,"gmtModify":1676534011910,"author":{"id":"3572299667195288","authorId":"3572299667195288","name":"Alvinkctan","avatar":"https://static.tigerbbs.com/ac39a5e87d43693bb506461fb259a3ba","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572299667195288","authorIdStr":"3572299667195288"},"themes":[],"htmlText":"Noted. Thank you.&nbsp;","listText":"Noted. Thank you.&nbsp;","text":"Noted. Thank you.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094785972","repostId":"1154007444","repostType":2,"repost":{"id":"1154007444","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1645225649,"share":"https://ttm.financial/m/news/1154007444?lang=&edition=fundamental","pubTime":"2022-02-19 07:07","market":"us","language":"zh","title":"昨夜今晨 | 俄乌局势惊扰市场！美股连跌两周","url":"https://stock-news.laohu8.com/highlight/detail?id=1154007444","media":"老虎资讯综合","summary":"摘要：三大指数集体收跌，热门中概股普跌；防止“炒股风波”重演！美联储出台全面交易限制；纽约联储质疑升息50基点必要性；重要芯片研发进程滞后，英特尔股价大跌逾5%>>>海外市场收盘：俄乌局势惊扰市场，美","content":"<html><head></head><body><blockquote><b>摘要：</b>三大指数集体收跌，热门中概股普跌；防止“炒股风波”重演！美联储出台全面交易限制；纽约联储质疑升息50基点必要性；重要芯片研发进程滞后，<a href=\"https://laohu8.com/S/INTC\">英特尔</a>股价大跌逾5%&gt;&gt;&gt;</blockquote><p><b>海外市场</b></p><p><b>收盘：俄乌局势惊扰市场，美股连续第二周下滑</b></p><p>俄乌局势和加息前景仍在主导市场情绪，三大指数悉数收跌，纳指跌超1%，美股市场连续第二周录得下跌。截至收盘，道琼斯指数跌0.68%，报34,079.18点；标普500指数跌0.72%，报4,348.87点；纳斯达克指数跌1.23%，报13,548.07点。</p><p><b>热门中概股收盘普跌，<a href=\"https://laohu8.com/S/ZH\">知乎</a>跌超12%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超6%</b></p><p>热门中概股集体下挫，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌4.37%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌3.61%，微博跌5.16%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌6.05%，哔哩哔哩跌6.19%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌5.22%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌3.18%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌1.32%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌5.68%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌6.58%，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌5.40%，知乎跌超12%，<a href=\"https://laohu8.com/S/YMM\">满帮</a>跌11.34%。</p><p><b>WTI原油期货收跌0.8%，本周下跌2.2%</b></p><p>原油期货价格周五收跌，使其周跌幅扩大至2%以上。纽约商品交易所3月交割的西德克萨斯中质原油（WTI）期货价格下跌69美分，跌幅近0.8%，收于每桶91.07美元。本周近月WTI合约下跌2.2%。</p><p><b>黄金期货收跌0.1%，本周上涨3.1%创9个月来最大周涨幅</b></p><p>黄金期货周五收低。在乌克兰危机推动下，金价周四升至八个月以来的最高收盘价，帮助其本周创下九个月以来的最大单周涨幅。纽约商品交易所4月交割的黄金期货价格下跌2.20美元，跌幅为0.1%，收于每盎司1899.80美元。本周黄金期货价格上涨3.1%，是2021年5月以来的最大单周涨幅。</p><p><b>欧股收盘普跌，德国DAX指数跌1.46%</b></p><p>德国DAX指数跌1.46%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.31%，法国CAC40指数跌0.25%，欧洲斯托克50指数跌0.94%。</p><p><b>国际宏观</b></p><p><a href=\"https://ttm.financial/NW/2212467873\" target=\"_blank\"><b>美联储鸽派官员呼吁实质性调整政策，纽约联储质疑升息50基点必要性</b></a></p><p>美联储最鸽派的官员之一呼吁“实质性调整”货币政策，但淡化了激进紧缩的必要性，这是第二位反对下月加息50基点的美联储官员。芝加哥联储行长Charles Evans和纽约联储行长John Williams都明确给出了将在3月15-16日会议上加息25个基点的信号，但核心官员对最终需要降息多少仍持开放态度。</p><p><a href=\"https://ttm.financial/NW/2212733986\" target=\"_blank\"><b>美联储理事布雷纳德：在3月份会议上启动一系列加息是合适的</b></a></p><p>美联储理事布雷纳德表示，美联储已经准备好在下个月加息，并在未来的几次会议上决定开始缩减资产负债表。“鉴于我们已经看到了非常强劲的数据，我的确预计，在下一次会议上启动一系列加息是合适的，” 布雷纳德周五在芝加哥大学布斯商学院于纽约主办的一次会议的小组讨论中表示。</p><p><a href=\"https://ttm.financial/NW/2212678496\" target=\"_blank\"><b>美联储宣布全面的交易限制，以防再度发生道德丑闻</b></a></p><p>美联储正式对央行官员的投资和交易行为采取严厉而全面的限制，以防再次发生去年那种让美联储蒙羞的道德丑闻。这些变动以法规形式确定了去年10月宣布的限制主动交易的指导方针，禁止买卖个股，并提高决策者和高级工作人员的披露要求。</p><p><a href=\"https://ttm.financial/NW/2212518673\" target=\"_blank\"><b>拜登签署临时拨款法案，避免美国联邦政府停摆</b></a></p><p>美国总统拜登正式签署了美国国会参议院17日晚间通过的临时拨款法案，确保联邦政府有足够资金继续运转到3月11日，暂时避免了联邦政府停摆的窘境。</p><p><b>公司新闻</b></p><p><a href=\"https://ttm.financial/NW/2212466675\" target=\"_blank\"><b>报道称SpaceX按1:10拆股，为该公司首次股票拆分</b></a></p><p>据报道，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>CEO埃隆-马斯克（Elon Musk）旗下太空探索公司SpaceX正在以1：10的比例拆分其普通股，该公司的估值已飙升至超过1000亿美元。</p><p><a href=\"https://ttm.financial/NW/2212267597\" target=\"_blank\"><b>Roku和特斯拉等股票下跌让木头姐的投资组合再受打击</b></a></p><p>木头姐Cathie Wood刚刚形容自己的投机性科技板块策略是一个“深度价值”投资组合，里面很多被低估的公司，但又一个动荡的交易日让她持有的一些大牌股票跌得更深了。美国股市周五下跌，2.2万亿美元期权到期放大了股市跌幅。Wood钟爱的Roku、特斯拉等股票也未能幸免，其中Roku暴跌22%，特斯拉下跌2%。</p><p><a href=\"https://ttm.financial/NW/2212471627\" target=\"_blank\"><b>莫德纳宣布启动疱疹病毒、癌症mRNA疫苗研发</b></a></p><p>生物医药企业莫德纳（Moderna）发布公告称，公司新增了三个mRNA疫苗开发项目，将使用与Spikevax新冠疫苗相同的技术。根据公告披露，三个新项目中，mRNA-1608候选疫苗旨在预防二型单纯疱疹病毒（HSV-2）；mRNA-1468疫苗用于降低水痘带状疱疹病毒的发病率；mRNA-4359用来测试这项技术治疗癌症的应用前景。</p><p><b><a href=\"https://laohu8.com/S/GM\">通用汽车</a>向NHTSA申请批准部署自动驾驶汽车</b></p><p>通用汽车和其自动驾驶技术子公司Cruise周五表示，已向美国监管机构申请建造和部署一款自动驾驶汽车。这款汽车名为Cruise Origin，特点是不具备方向盘或刹车踏板等人工控制的部件。通用汽车和Cruise于2020年10月首次披露Cruise Origin，并计划在几个月内获得美国国家公路交通安全管理局(NHTSA)的批准。</p><p><a href=\"https://ttm.financial/NW/1176574333\" target=\"_blank\"><b>重要芯片研发进程滞后，英特尔股价大跌逾5%</b></a><b></b></p><p>英特尔股价周五收跌5.32%，原因是该公司首席执行官Pat Gelsinger周四证实，代号为Granite Rapids的服务器芯片将从2023年推迟至2024年，未来两年将不得不投入大量资金才能追上竞争对手。Granite Rapids是英特尔首款使用超紫外光刻技术的服务器处理器，这是英特尔追赶<a href=\"https://laohu8.com/S/TSM\">台积电</a>和其他顶级芯片制造商所需的关键技术。</p><p><b>爱马仕Q4财报不如预期，产能设限影响业绩</b></p><p>当地时间周五，法国奢侈品巨头爱马仕发布四季度及全年财报。数据显示，公司四季度总营收达到23.8亿欧元，以不变汇率计算同比增长11%，在奢侈品供不应求的大背景下逊于分析师预期的12%。究其原因，主要是皮具及马具部门营收下降逾5%，即便其他业务大都交出超过20%的增速，也抵不过第一大业务板块营收下降带来的影响。爱马仕CEO阿克塞尔·杜马斯透露，产能有限限制了公司业绩增长，做一个爱马仕的皮包需要15个小时的工序，尽管集团每年会招募400名工匠，但考虑到需要大量时间培训，产能的增长十分有限。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨 | 俄乌局势惊扰市场！美股连跌两周</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨 | 俄乌局势惊扰市场！美股连跌两周\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2022-02-19 07:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><blockquote><b>摘要：</b>三大指数集体收跌，热门中概股普跌；防止“炒股风波”重演！美联储出台全面交易限制；纽约联储质疑升息50基点必要性；重要芯片研发进程滞后，<a href=\"https://laohu8.com/S/INTC\">英特尔</a>股价大跌逾5%&gt;&gt;&gt;</blockquote><p><b>海外市场</b></p><p><b>收盘：俄乌局势惊扰市场，美股连续第二周下滑</b></p><p>俄乌局势和加息前景仍在主导市场情绪，三大指数悉数收跌，纳指跌超1%，美股市场连续第二周录得下跌。截至收盘，道琼斯指数跌0.68%，报34,079.18点；标普500指数跌0.72%，报4,348.87点；纳斯达克指数跌1.23%，报13,548.07点。</p><p><b>热门中概股收盘普跌，<a href=\"https://laohu8.com/S/ZH\">知乎</a>跌超12%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超6%</b></p><p>热门中概股集体下挫，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌4.37%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌3.61%，微博跌5.16%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌6.05%，哔哩哔哩跌6.19%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌5.22%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌3.18%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌1.32%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌5.68%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌6.58%，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌5.40%，知乎跌超12%，<a href=\"https://laohu8.com/S/YMM\">满帮</a>跌11.34%。</p><p><b>WTI原油期货收跌0.8%，本周下跌2.2%</b></p><p>原油期货价格周五收跌，使其周跌幅扩大至2%以上。纽约商品交易所3月交割的西德克萨斯中质原油（WTI）期货价格下跌69美分，跌幅近0.8%，收于每桶91.07美元。本周近月WTI合约下跌2.2%。</p><p><b>黄金期货收跌0.1%，本周上涨3.1%创9个月来最大周涨幅</b></p><p>黄金期货周五收低。在乌克兰危机推动下，金价周四升至八个月以来的最高收盘价，帮助其本周创下九个月以来的最大单周涨幅。纽约商品交易所4月交割的黄金期货价格下跌2.20美元，跌幅为0.1%，收于每盎司1899.80美元。本周黄金期货价格上涨3.1%，是2021年5月以来的最大单周涨幅。</p><p><b>欧股收盘普跌，德国DAX指数跌1.46%</b></p><p>德国DAX指数跌1.46%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.31%，法国CAC40指数跌0.25%，欧洲斯托克50指数跌0.94%。</p><p><b>国际宏观</b></p><p><a href=\"https://ttm.financial/NW/2212467873\" target=\"_blank\"><b>美联储鸽派官员呼吁实质性调整政策，纽约联储质疑升息50基点必要性</b></a></p><p>美联储最鸽派的官员之一呼吁“实质性调整”货币政策，但淡化了激进紧缩的必要性，这是第二位反对下月加息50基点的美联储官员。芝加哥联储行长Charles Evans和纽约联储行长John Williams都明确给出了将在3月15-16日会议上加息25个基点的信号，但核心官员对最终需要降息多少仍持开放态度。</p><p><a href=\"https://ttm.financial/NW/2212733986\" target=\"_blank\"><b>美联储理事布雷纳德：在3月份会议上启动一系列加息是合适的</b></a></p><p>美联储理事布雷纳德表示，美联储已经准备好在下个月加息，并在未来的几次会议上决定开始缩减资产负债表。“鉴于我们已经看到了非常强劲的数据，我的确预计，在下一次会议上启动一系列加息是合适的，” 布雷纳德周五在芝加哥大学布斯商学院于纽约主办的一次会议的小组讨论中表示。</p><p><a href=\"https://ttm.financial/NW/2212678496\" target=\"_blank\"><b>美联储宣布全面的交易限制，以防再度发生道德丑闻</b></a></p><p>美联储正式对央行官员的投资和交易行为采取严厉而全面的限制，以防再次发生去年那种让美联储蒙羞的道德丑闻。这些变动以法规形式确定了去年10月宣布的限制主动交易的指导方针，禁止买卖个股，并提高决策者和高级工作人员的披露要求。</p><p><a href=\"https://ttm.financial/NW/2212518673\" target=\"_blank\"><b>拜登签署临时拨款法案，避免美国联邦政府停摆</b></a></p><p>美国总统拜登正式签署了美国国会参议院17日晚间通过的临时拨款法案，确保联邦政府有足够资金继续运转到3月11日，暂时避免了联邦政府停摆的窘境。</p><p><b>公司新闻</b></p><p><a href=\"https://ttm.financial/NW/2212466675\" target=\"_blank\"><b>报道称SpaceX按1:10拆股，为该公司首次股票拆分</b></a></p><p>据报道，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>CEO埃隆-马斯克（Elon Musk）旗下太空探索公司SpaceX正在以1：10的比例拆分其普通股，该公司的估值已飙升至超过1000亿美元。</p><p><a href=\"https://ttm.financial/NW/2212267597\" target=\"_blank\"><b>Roku和特斯拉等股票下跌让木头姐的投资组合再受打击</b></a></p><p>木头姐Cathie Wood刚刚形容自己的投机性科技板块策略是一个“深度价值”投资组合，里面很多被低估的公司，但又一个动荡的交易日让她持有的一些大牌股票跌得更深了。美国股市周五下跌，2.2万亿美元期权到期放大了股市跌幅。Wood钟爱的Roku、特斯拉等股票也未能幸免，其中Roku暴跌22%，特斯拉下跌2%。</p><p><a href=\"https://ttm.financial/NW/2212471627\" target=\"_blank\"><b>莫德纳宣布启动疱疹病毒、癌症mRNA疫苗研发</b></a></p><p>生物医药企业莫德纳（Moderna）发布公告称，公司新增了三个mRNA疫苗开发项目，将使用与Spikevax新冠疫苗相同的技术。根据公告披露，三个新项目中，mRNA-1608候选疫苗旨在预防二型单纯疱疹病毒（HSV-2）；mRNA-1468疫苗用于降低水痘带状疱疹病毒的发病率；mRNA-4359用来测试这项技术治疗癌症的应用前景。</p><p><b><a href=\"https://laohu8.com/S/GM\">通用汽车</a>向NHTSA申请批准部署自动驾驶汽车</b></p><p>通用汽车和其自动驾驶技术子公司Cruise周五表示，已向美国监管机构申请建造和部署一款自动驾驶汽车。这款汽车名为Cruise Origin，特点是不具备方向盘或刹车踏板等人工控制的部件。通用汽车和Cruise于2020年10月首次披露Cruise Origin，并计划在几个月内获得美国国家公路交通安全管理局(NHTSA)的批准。</p><p><a href=\"https://ttm.financial/NW/1176574333\" target=\"_blank\"><b>重要芯片研发进程滞后，英特尔股价大跌逾5%</b></a><b></b></p><p>英特尔股价周五收跌5.32%，原因是该公司首席执行官Pat Gelsinger周四证实，代号为Granite Rapids的服务器芯片将从2023年推迟至2024年，未来两年将不得不投入大量资金才能追上竞争对手。Granite Rapids是英特尔首款使用超紫外光刻技术的服务器处理器，这是英特尔追赶<a href=\"https://laohu8.com/S/TSM\">台积电</a>和其他顶级芯片制造商所需的关键技术。</p><p><b>爱马仕Q4财报不如预期，产能设限影响业绩</b></p><p>当地时间周五，法国奢侈品巨头爱马仕发布四季度及全年财报。数据显示，公司四季度总营收达到23.8亿欧元，以不变汇率计算同比增长11%，在奢侈品供不应求的大背景下逊于分析师预期的12%。究其原因，主要是皮具及马具部门营收下降逾5%，即便其他业务大都交出超过20%的增速，也抵不过第一大业务板块营收下降带来的影响。爱马仕CEO阿克塞尔·杜马斯透露，产能有限限制了公司业绩增长，做一个爱马仕的皮包需要15个小时的工序，尽管集团每年会招募400名工匠，但考虑到需要大量时间培训，产能的增长十分有限。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154007444","content_text":"摘要：三大指数集体收跌，热门中概股普跌；防止“炒股风波”重演！美联储出台全面交易限制；纽约联储质疑升息50基点必要性；重要芯片研发进程滞后，英特尔股价大跌逾5%>>>海外市场收盘：俄乌局势惊扰市场，美股连续第二周下滑俄乌局势和加息前景仍在主导市场情绪，三大指数悉数收跌，纳指跌超1%，美股市场连续第二周录得下跌。截至收盘，道琼斯指数跌0.68%，报34,079.18点；标普500指数跌0.72%，报4,348.87点；纳斯达克指数跌1.23%，报13,548.07点。热门中概股收盘普跌，知乎跌超12%，哔哩哔哩跌超6%热门中概股集体下挫，阿里巴巴跌4.37%，京东跌3.61%，微博跌5.16%，拼多多跌6.05%，哔哩哔哩跌6.19%，百度跌5.22%，新东方跌3.18%，网易跌1.32%，腾讯音乐跌5.68%，爱奇艺跌6.58%，滴滴跌5.40%，知乎跌超12%，满帮跌11.34%。WTI原油期货收跌0.8%，本周下跌2.2%原油期货价格周五收跌，使其周跌幅扩大至2%以上。纽约商品交易所3月交割的西德克萨斯中质原油（WTI）期货价格下跌69美分，跌幅近0.8%，收于每桶91.07美元。本周近月WTI合约下跌2.2%。黄金期货收跌0.1%，本周上涨3.1%创9个月来最大周涨幅黄金期货周五收低。在乌克兰危机推动下，金价周四升至八个月以来的最高收盘价，帮助其本周创下九个月以来的最大单周涨幅。纽约商品交易所4月交割的黄金期货价格下跌2.20美元，跌幅为0.1%，收于每盎司1899.80美元。本周黄金期货价格上涨3.1%，是2021年5月以来的最大单周涨幅。欧股收盘普跌，德国DAX指数跌1.46%德国DAX指数跌1.46%，英国富时100指数跌0.31%，法国CAC40指数跌0.25%，欧洲斯托克50指数跌0.94%。国际宏观美联储鸽派官员呼吁实质性调整政策，纽约联储质疑升息50基点必要性美联储最鸽派的官员之一呼吁“实质性调整”货币政策，但淡化了激进紧缩的必要性，这是第二位反对下月加息50基点的美联储官员。芝加哥联储行长Charles Evans和纽约联储行长John Williams都明确给出了将在3月15-16日会议上加息25个基点的信号，但核心官员对最终需要降息多少仍持开放态度。美联储理事布雷纳德：在3月份会议上启动一系列加息是合适的美联储理事布雷纳德表示，美联储已经准备好在下个月加息，并在未来的几次会议上决定开始缩减资产负债表。“鉴于我们已经看到了非常强劲的数据，我的确预计，在下一次会议上启动一系列加息是合适的，” 布雷纳德周五在芝加哥大学布斯商学院于纽约主办的一次会议的小组讨论中表示。美联储宣布全面的交易限制，以防再度发生道德丑闻美联储正式对央行官员的投资和交易行为采取严厉而全面的限制，以防再次发生去年那种让美联储蒙羞的道德丑闻。这些变动以法规形式确定了去年10月宣布的限制主动交易的指导方针，禁止买卖个股，并提高决策者和高级工作人员的披露要求。拜登签署临时拨款法案，避免美国联邦政府停摆美国总统拜登正式签署了美国国会参议院17日晚间通过的临时拨款法案，确保联邦政府有足够资金继续运转到3月11日，暂时避免了联邦政府停摆的窘境。公司新闻报道称SpaceX按1:10拆股，为该公司首次股票拆分据报道，特斯拉CEO埃隆-马斯克（Elon Musk）旗下太空探索公司SpaceX正在以1：10的比例拆分其普通股，该公司的估值已飙升至超过1000亿美元。Roku和特斯拉等股票下跌让木头姐的投资组合再受打击木头姐Cathie Wood刚刚形容自己的投机性科技板块策略是一个“深度价值”投资组合，里面很多被低估的公司，但又一个动荡的交易日让她持有的一些大牌股票跌得更深了。美国股市周五下跌，2.2万亿美元期权到期放大了股市跌幅。Wood钟爱的Roku、特斯拉等股票也未能幸免，其中Roku暴跌22%，特斯拉下跌2%。莫德纳宣布启动疱疹病毒、癌症mRNA疫苗研发生物医药企业莫德纳（Moderna）发布公告称，公司新增了三个mRNA疫苗开发项目，将使用与Spikevax新冠疫苗相同的技术。根据公告披露，三个新项目中，mRNA-1608候选疫苗旨在预防二型单纯疱疹病毒（HSV-2）；mRNA-1468疫苗用于降低水痘带状疱疹病毒的发病率；mRNA-4359用来测试这项技术治疗癌症的应用前景。通用汽车向NHTSA申请批准部署自动驾驶汽车通用汽车和其自动驾驶技术子公司Cruise周五表示，已向美国监管机构申请建造和部署一款自动驾驶汽车。这款汽车名为Cruise Origin，特点是不具备方向盘或刹车踏板等人工控制的部件。通用汽车和Cruise于2020年10月首次披露Cruise Origin，并计划在几个月内获得美国国家公路交通安全管理局(NHTSA)的批准。重要芯片研发进程滞后，英特尔股价大跌逾5%英特尔股价周五收跌5.32%，原因是该公司首席执行官Pat Gelsinger周四证实，代号为Granite Rapids的服务器芯片将从2023年推迟至2024年，未来两年将不得不投入大量资金才能追上竞争对手。Granite Rapids是英特尔首款使用超紫外光刻技术的服务器处理器，这是英特尔追赶台积电和其他顶级芯片制造商所需的关键技术。爱马仕Q4财报不如预期，产能设限影响业绩当地时间周五，法国奢侈品巨头爱马仕发布四季度及全年财报。数据显示，公司四季度总营收达到23.8亿欧元，以不变汇率计算同比增长11%，在奢侈品供不应求的大背景下逊于分析师预期的12%。究其原因，主要是皮具及马具部门营收下降逾5%，即便其他业务大都交出超过20%的增速，也抵不过第一大业务板块营收下降带来的影响。爱马仕CEO阿克塞尔·杜马斯透露，产能有限限制了公司业绩增长，做一个爱马仕的皮包需要15个小时的工序，尽管集团每年会招募400名工匠，但考虑到需要大量时间培训，产能的增长十分有限。","news_type":1},"isVote":1,"tweetType":1,"viewCount":715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}